Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-14

Clinical Trial Update: Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy [NA]

View source ↗

Summary

An update on a clinical study evaluating neuromodulation as a treatment for chemotherapy-induced peripheral neuropathy; the trial is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pain | NA | Status: ACTIVE_NOT_RECRUITING